Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity.
about
The behavior of matrix metalloproteinases and their inhibitors in colorectal cancerECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammationImbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel diseaseExpression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitisPlasma interleukin-18 reflects severity of ulcerative colitis.Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.Correlation of plasma MMP-1 and TIMP-1 levels and the colonic mucosa expressions in patients with ulcerative colitis.Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseasesMatrix metalloproteinases: do they play a role in mucosal pathology of the oral cavity?Impact of proteolytic enzymes in colorectal cancer development and progression.The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases.A local imbalance between MMP and TIMP may have an implication on the severity and course of appendicitis.Correlation between serum matrix metalloproteinase and antigenemia levels in patients infected with rotavirus.Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?Candidate Serum Markers in Early Crohn's Disease: Predictors of Disease Course.The Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases
P2860
Q27004958-023D1042-28B0-45DA-BE6F-48C34588AF23Q27015979-E64FD28B-7DF8-43B6-A85D-2A0376BE497BQ33387401-3A7D4339-6E32-40FF-A33C-0317475E380FQ34013098-F2942E33-163E-47CC-8EBF-076291B8DA41Q34605860-EB92A9B8-B84F-459C-B37D-1B5C44A57C45Q35553707-B41D6823-28A9-40F1-B611-91BB8192CCDAQ37414656-E5913E3B-6334-4C4C-91FF-B6C861453BCBQ37706103-4DF1B2F7-E29A-496F-960D-570B6BDDC72AQ38049159-ADFFE228-07E7-4AEE-8166-8BAA5ADA50E2Q38259533-EC8855F4-4A99-43A0-AAFE-5C5743695F30Q38881849-F012C793-0C9F-4343-8A37-7DB7CBBE3EE6Q42004360-489AE97A-6C33-4B63-89E6-9315465796E2Q43712767-7B45F21C-08EC-4B20-91D3-8747D7E9D99EQ47258530-8666A524-A7D5-409E-AC2B-09BCF95AABA9Q50755835-F39DF136-70E2-451F-A829-E5B33129429EQ58427369-85B6984C-BDDC-483F-9CFD-E4FF4B222F5B
P2860
Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Plasma matrix metalloproteinas ...... f ulcerative colitis activity.
@ast
Plasma matrix metalloproteinas ...... f ulcerative colitis activity.
@en
type
label
Plasma matrix metalloproteinas ...... f ulcerative colitis activity.
@ast
Plasma matrix metalloproteinas ...... f ulcerative colitis activity.
@en
prefLabel
Plasma matrix metalloproteinas ...... f ulcerative colitis activity.
@ast
Plasma matrix metalloproteinas ...... f ulcerative colitis activity.
@en
P2860
P50
P356
P1476
Plasma matrix metalloproteinas ...... of ulcerative colitis activity
@en
P2093
Danuta Prokopowicz
P2860
P304
P356
10.3748/WJG.V9.I12.2843
P407
P577
2003-12-01T00:00:00Z